Luteinizing hormone-releasing hormone agonist and transferrin functionalizations enhance nanoparticle delivery in a novel bovine ex vivo eye model

Molecular Vision

Volumn 12, Issue , 2006, Pages

  Kompella, Uday B ^a,b   Sundaram, Sneha ^a   Raghava, Swita ^a   Escobar, Edith R ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; DESLORELIN; GONADORELIN AGONIST; GONADORELIN RECEPTOR; MANNITOL; MESSENGER RNA; POLYSTYRENE; PROTEIN ZO1; TRANSFERRIN; TRANSFERRIN RECEPTOR; DRUG DERIVATIVE; EYE DROPS; GONADORELIN; NANOPARTICLE; TRIPTORELIN;

ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA EPITHELIUM; CORNEA STROMA; COW; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG TRANSPORT; EX VIVO STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MEMBRANE PERMEABILITY; NANOPARTICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VALIDATION PROCESS; WESTERN BLOTTING; ANIMAL; CATTLE; CHEMISTRY; CONFOCAL MICROSCOPY; CORNEA; DRUG POTENTIATION; EYE; GENETICS; METABOLISM; PHYSICAL CHEMISTRY; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; VALIDATION STUDY;

ANIMALS; BIOLOGICAL TRANSPORT; CATTLE; CHEMISTRY, PHYSICAL; CONJUNCTIVA; CORNEA; EPITHELIUM, CORNEAL; EYE; GONADOTROPIN-RELEASING HORMONE; MICROSCOPY, CONFOCAL; NANOPARTICLES; OPHTHALMIC SOLUTIONS; RECEPTORS, LHRH; RECEPTORS, TRANSFERRIN; RNA, MESSENGER; TRANSFERRIN; TRIPTORELIN;

EID: 33750383647     PISSN: 10900535     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Meadows DL, Paugh JR, Joshi A, Mordaunt J. A novel method to evaluate residence time in humans using a nonpenetrating fluorescent tracer. Invest Ophthalmol Vis Sci 2002; 43:1032-9.
2. Bourges JL, Gautier SE, Delie F, Bejjani RA, Jeanny JC, Gurny R, BenEzra D, Behar-Cohen FF. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest Ophthalmol Vis Sci 2003; 44:3562-9.
3. Merodio M, Irache JM, Valamanesh F, Mirshahi M. Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats. Biomaterials 2002; 23:1587-94.
4. Marchal-Heussler L, Sirbat D, Hoffman M, Maincent P. Poly(epsilon-caprolactone) nanocapsules in carteolol ophthalmic delivery. Pharm Res 1993; 10:386-90.
5. Kompella UB, Bandi N, Ayalasomayajula SP. Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest Ophthalmol Vis Sci 2003; 44:1192-201.
6. Amrite AC, Ayalasomayajula SP, Cheruvu NP, Kompella UB. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage. Invest Ophthalmol Vis Sci 2006; 47:1149-60.
7. Amrite AC, Kompella UB. Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration. J Pharm Pharmacol 2005; 57:1555-63.
8. Giannavola C, Bucolo C, Maltese A, Paolino D, Vandelli MA, Puglisi G, Lee VH, Fresta M. Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability. Pharm Res 2003; 20:584-90.
9. Wood RW, Li VH, Kreuter J, Robinson JR. Ocular disposition of poly-hexyl-2-cyano[3-14C]acrylate nanoparticles in the albino rabbit. Int J Pharm 1985; 23:175-183.
10. de Campos AM, Diebold Y, Carvalho EL, Sanchez A, Alonso MJ. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res 2004; 21:803-10. Erratum in: Pharm Res. 2005; 22:1007.
11. De Campos AM, Sanchez A, Alonso MJ. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm 2001; 224:159-68.
12. Aukunuru JV, Ayalasomayajula SP, Kompella UB. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells. J Pharm Pharmacol 2003; 55:1199-206.
13. Aukunuru JV, Kompella UB. In vitro delivery of nano- and micro- particles to retinal pigment epithelial (RPE) cells. Drug Del Technol 2002; 2:50-57.
14. Bandi N, Kompella UB. Budesonide reduces multidrug resistance-associated protein 1 expression in an airway epithelial cell line (Calu-1). Eur J Pharmacol 2002; 437:9-17.
15. Roth C, Schricker M, Lakomek M, Strege A, Heiden I, Luft H, Munzel U, Wuttke W, Jarry H. Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model. J Endocrinol 2001; 169:361-71.
16. Schirman-Hildesheim TD, Bar T, Ben-Aroya N, Koch Y. Differential gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acid expression patterns in different tissues of the female rat across the estrous cycle. Endocrinology 2005; 146:3401-8.
17. Halmos G, Schally AV, Kahan Z. Down-regulation and change in subcellular distribution of receptors for luteinizing hormone-releasing hormone in OV-1063 human epithelial ovarian cancers during therapy with LH-RH antagonist Cetrorelix. Int J Oncol 2000; 17:367-73.
18. Kawabata H, Yang R, Hirama T, Vuong PT, Kawano S, Gombart AF, Koeffler HP. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 1999; 274:20826-32.
19. Wang Y, Chen M, Wolosin JM. ZO-1 in corneal epithelium; stratal distribution and synthesis induction by outer cell removal. Exp Eye Res 1993; 57:283-92.
20. Lauweryns B, van den Oord JJ, Missotten L. The transitional zone between limbus and peripheral cornea. An immunohistochemical study. Invest Ophthalmol Vis Sci 1993; 34:1991-9.
21. Qian ZM, Li H, Sun H, Ho K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 2002; 54:561-87.
22. Koushik K, Bandi N, Sundaram S, Kompella UB. Evidence for LHRH-receptor expression in human airway epithelial (Calu-3) cells and its role in the transport of an LHRH agonist. Pharm Res 2004; 21:1034-46.
23. Koushik KN, Kompella UB. Transport of deslorelin, an LHRH agonist, is vectorial and exhibits regional variation in excised bovine nasal tissue. J Pharm Pharmacol 2004; 56:861-8.
24. Kompella UB, Sunkara G, Thomas E, Clark CR, Deruiter J. Rabbit corneal and conjunctival permeability of the novel aldose reductase inhibitors: N- 4-(benzoylamino)phenyl] sulphonyl]glycines and N-benzoyl-N-phenylglycines. J Pharm Pharmacol 1999; 51:921-7.
25. Kompella UB, Kim KJ, Lee VH. Active chloride transport in the pigmented rabbit conjunctiva. Curr Eye Res 1993; 12:1041-8.
26. Zimmer A, Kreuter J, Robinson JR. Studies on the transport pathway of PBCA nanoparticles in ocular tissues. J Microencapsul 1991; 8:497-504.
27. Losa C, Calvo P, Castro E, Vila-Jato JL, Alonso MJ. Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles. J Pharm Pharmacol 1991; 43:548-52.